After months of dedicated advocacy alongside survivors, families, and clinicians, the bipartisan Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing (IMPACT) Act has officially been introduced in Congress. Championed by Senators Elissa Slotkin (D-MI) and Katie Britt (R-AL) in the Senate, and Representatives Rosa DeLauro (D-CT-03) and Don Bacon (R-NE-01) in the House, this bill … Continued
Ovarian Cancer IMPACT Act would expand access to genetic testing and counseling, risk-reducing care, education and specialized care for patients and families WASHINGTON, D.C. — September 29, 2026 — Ovarian Cancer Research Alliance (OCRA) today joined patients, survivors, and advocates in celebrating the introduction of the Ovarian Cancer Improving and Modernizing Prevention, Access, Care, and Testing … Continued
Written by Julia Thayer, OCRA’s Associate Director, Advocacy September is Ovarian Cancer Awareness Month and Gynecologic Cancer Awareness Month. It is a time to not only honor everyone impacted by these diseases, but also remember those we have lost and recommit ourselves to creating meaningful change. Bipartisan Ovarian Cancer IMPACT Act Introduced in Congress This month, … Continued
Written by Julia Thayer, OCRA’s Associate Director, Advocacy Advocacy Works. And We Need Your Voice. Every day, people impacted by gynecologic cancers are using their voices to create change, and OCRA’s Advocate Leaders are at the heart of that work. This past year, our Advocate Leaders have shown just how powerful advocacy can be: These numbers … Continued
Written by Julia Thayer, OCRA’s Associate Director, Advocacy Federal Rulemaking Update: Proposed Update to Uniform Guidance Advocacy isn’t limited to legislation and federal funding. This month, OCRA submitted a public comment on a proposed federal rule that could significantly impact how biomedical research is funded and conducted. On May 29, 2026, the Office of Management … Continued
Nearly 500 people have already registered for OCRA’s International Gynecologic Cancer Conference®—the largest conference dedicated to the gynecologic cancer community—taking place on September 16–17. The conference is free, online, and open to all, and will include programming for ovarian, endometrial, cervical, and rare gynecologic cancers. For the first time, each of these diseases will have a dedicated Ask the Experts session. Learn … Continued
Written by Julia Thayer, OCRA’s Associate Director, Advocacy Federal Funding Update: Two Priorities Gain Ground There’s encouraging news to share from this year’s federal funding process: two of OCRA’s top priorities are in line for more funding than they received last year. The House Appropriations Committee has recommended increases for both Johanna’s Law and the … Continued
Written by Julia Thayer, Associate Director, Advocacy There have been several exciting advocacy developments in recent weeks, especially at the state level, where advocates and coalition partners continue advancing efforts to expand access to biomarker testing and improve patient care. Tennessee Becomes the 24th State with Comprehensive Biomarker Testing Coverage Earlier in May, Tennessee officially … Continued
Accelerating the Mission: OCRA President & CEO Audra Moran Named a Crain’s 2026 Notable Leader in Health Care Ovarian Cancer Research Alliance (OCRA) is proud to share that President and CEO Audra Moran has been named a Crain’s New York Business 2026 Notable Leader in Health Care—an annual recognition honoring executives whose leadership, innovation, and … Continued
Written by Julia Thayer, Associate Director, Advocacy FY2027 Budget Update & Advocacy Momentum As we continue through appropriations season, we wanted to share a quick update on the President’s proposed FY2027 budget and what it means for our community. While we’re still awaiting full details, there are a few key takeaways to highlight. A quick … Continued
OCRA’s Annual Advocacy Day Draws Survivors and Caregivers from Across the Country More than 120 gynecologic cancer survivors, caregivers, researchers and supporters from nearly forty states filled the halls of the U.S. Capitol on Tuesday, March 17—dressed in teal, the color of ovarian cancer awareness—as Ovarian Cancer Research Alliance (OCRA) held its annual Spring Advocacy Day. The … Continued
Written by Julia Thayer, Associate Director, Advocacy This month, more than 120 OCRA Advocate Leaders traveled to Washington, DC for Advocacy Day—braving snowstorms, severe weather, and even a partial government shutdown to make their voices heard on Capitol Hill. We kicked things off with a full day of training, where the group built skills, shared stories, and … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
